MBX•benzinga•
JMP Securities Initiates Coverage On MBX Biosciences with Market Outperform Rating, Announces Price Target of $38
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga